Matches in Nanopublications for { ?s ?p "[In contrast, only 7% of primary high-grade acinar carcinomas (10 of 150), 11% of primary acinar carcinomas with neuroendocrine differentiation (4 of 35), and 15% of metastatic castrate-resistant acinar carcinomas (2 of 13) showed Rb protein loss.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1135326.RAc9Q6MySkYLr8kLJTCQJKKRkmZTM1JDf2y0UIXZidfb8130_assertion description "[In contrast, only 7% of primary high-grade acinar carcinomas (10 of 150), 11% of primary acinar carcinomas with neuroendocrine differentiation (4 of 35), and 15% of metastatic castrate-resistant acinar carcinomas (2 of 13) showed Rb protein loss.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1135326.RAc9Q6MySkYLr8kLJTCQJKKRkmZTM1JDf2y0UIXZidfb8130_provenance.
- NP667058.RAE_sZqEJU5ksLj4L-kxG-O3TbIOwbQrP3JhXFr_R4_5Q130_assertion description "[In contrast, only 7% of primary high-grade acinar carcinomas (10 of 150), 11% of primary acinar carcinomas with neuroendocrine differentiation (4 of 35), and 15% of metastatic castrate-resistant acinar carcinomas (2 of 13) showed Rb protein loss.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667058.RAE_sZqEJU5ksLj4L-kxG-O3TbIOwbQrP3JhXFr_R4_5Q130_provenance.